XML 51 R38.htm IDEA: XBRL DOCUMENT v3.22.2
Product Revenue, Net - Narrative (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Disaggregation of Revenue [Line Items]        
Revenue $ 2,526,000 $ 1,313,000 $ 2,994,000 $ 7,895,000
Contract with customer product sales gross to net accruals   0   0
Gross product revenue | Customer | Cardinal Health        
Disaggregation of Revenue [Line Items]        
Concentration risk (percent) 22.70%   21.70%  
Gross product revenue | Customer | AmerisourceBergen Drug Corporation        
Disaggregation of Revenue [Line Items]        
Concentration risk (percent) 40.20%   35.10%  
Gross product revenue | Customer | McKesson Corporation        
Disaggregation of Revenue [Line Items]        
Concentration risk (percent) 24.60%   22.50%  
IBSRELA        
Disaggregation of Revenue [Line Items]        
Revenue $ 1,600,000   $ 2,000,000  
Product sales, net        
Disaggregation of Revenue [Line Items]        
Revenue $ 1,564,000 $ 0 $ 2,014,000 $ 0